Do PCSK9 Monoclonal Antibodies plus SOC Prevent Major Adverse Cardiovascular Events in Adults with Hypercholesterolemia Compared to Placebo Plus SOC
2016
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI